Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria (PAFCUTIII)

This study has been completed.
Sponsor:
Collaborator:
Hospital del Mar
Information provided by (Responsible Party):
Marina Abajian, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01605487
First received: May 11, 2012
Last updated: October 14, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)